290 related articles for article (PubMed ID: 33372981)
1. Hydrogen Sulfide: A Potential Therapeutic Target in the Development of Diabetic Retinopathy.
Mohammad G; Radhakrishnan R; Kowluru RA
Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):35. PubMed ID: 33372981
[TBL] [Abstract][Full Text] [Related]
2. Exogenous Hydrogen Sulfide Attenuates Cardiac Fibrosis Through Reactive Oxygen Species Signal Pathways in Experimental Diabetes Mellitus Models.
Zheng D; Dong S; Li T; Yang F; Yu X; Wu J; Zhong X; Zhao Y; Wang L; Xu C; Lu F; Zhang W
Cell Physiol Biochem; 2015; 36(3):917-29. PubMed ID: 26088607
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.
Kowluru RA; Mohammad G; dos Santos JM; Zhong Q
Diabetes; 2011 Nov; 60(11):3023-33. PubMed ID: 21933988
[TBL] [Abstract][Full Text] [Related]
4. Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats.
Si YF; Wang J; Guan J; Zhou L; Sheng Y; Zhao J
Br J Pharmacol; 2013 Jun; 169(3):619-31. PubMed ID: 23488985
[TBL] [Abstract][Full Text] [Related]
5. Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.
Kowluru RA; Santos JM; Zhong Q
Invest Ophthalmol Vis Sci; 2014 Jun; 55(9):5653-60. PubMed ID: 24894401
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.
Kowluru RA; Kanwar M
Free Radic Biol Med; 2009 Jun; 46(12):1677-85. PubMed ID: 19345729
[TBL] [Abstract][Full Text] [Related]
7. Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy.
Kowluru RA; Shan Y
Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):955-962. PubMed ID: 28124145
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo.
Liu H; Anders F; Thanos S; Mann C; Liu A; Grus FH; Pfeiffer N; Prokosch-Willing V
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5129-5141. PubMed ID: 28986598
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide donor GYY4137 attenuates vascular complications in mesenteric bed of streptozotocin-induced diabetic rats.
Alshahwan H; Qabazard B; Mousa A; Chandrasekhar B; Santhosh K; Yousif MHM
Eur J Pharmacol; 2022 Oct; 933():175265. PubMed ID: 36108734
[TBL] [Abstract][Full Text] [Related]
10. GYY4137, an Extended-Release Hydrogen Sulfide Donor, Reduces NMDA-Induced Neuronal Injury in the Murine Retina.
Sone K; Mori A; Sakamoto K; Nakahara T
Biol Pharm Bull; 2018; 41(4):657-660. PubMed ID: 29607941
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide attenuates lung ischemia-reperfusion injury through SIRT3-dependent regulation of mitochondrial function in type 2 diabetic rats.
Jiang T; Liu Y; Meng Q; Lv X; Yue Z; Ding W; Liu T; Cui X
Surgery; 2019 May; 165(5):1014-1026. PubMed ID: 30824287
[TBL] [Abstract][Full Text] [Related]
12. GYY4137, a novel hydrogen sulfide-releasing molecule, likely protects against high glucose-induced cytotoxicity by activation of the AMPK/mTOR signal pathway in H9c2 cells.
Wei WB; Hu X; Zhuang XD; Liao LZ; Li WD
Mol Cell Biochem; 2014 Apr; 389(1-2):249-56. PubMed ID: 24374752
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine Disrupts Balance between MMP-9 and Its Tissue Inhibitor in Diabetic Retinopathy: The Role of DNA Methylation.
Mohammad G; Kowluru RA
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150828
[TBL] [Abstract][Full Text] [Related]
14. Exogenous hydrogen sulfide (H2S) protects alveolar growth in experimental O2-induced neonatal lung injury.
Vadivel A; Alphonse RS; Ionescu L; Machado DS; O'Reilly M; Eaton F; Haromy A; Michelakis ED; Thébaud B
PLoS One; 2014; 9(3):e90965. PubMed ID: 24603989
[TBL] [Abstract][Full Text] [Related]
15. Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy.
Zhong Q; Kowluru RA
Diabetes; 2013 Jul; 62(7):2559-68. PubMed ID: 23423566
[TBL] [Abstract][Full Text] [Related]
16. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.
Kanwar M; Chan PS; Kern TS; Kowluru RA
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3805-11. PubMed ID: 17652755
[TBL] [Abstract][Full Text] [Related]
17. Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy.
Santos JM; Tewari S; Lin JY; Kowluru RA
Biochem Biophys Res Commun; 2013 Sep; 438(4):760-4. PubMed ID: 23891690
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine and mitochondrial quality control in diabetic retinopathy.
Malaviya P; Kowluru RA
Eye Vis (Lond); 2024 Jan; 11(1):5. PubMed ID: 38229140
[TBL] [Abstract][Full Text] [Related]
19. The novel mitochondria-targeted hydrogen sulfide (H
Gerő D; Torregrossa R; Perry A; Waters A; Le-Trionnaire S; Whatmore JL; Wood M; Whiteman M
Pharmacol Res; 2016 Nov; 113(Pt A):186-198. PubMed ID: 27565382
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanism of Transcriptional Regulation of Matrix Metalloproteinase-9 in Diabetic Retinopathy.
Mishra M; Flaga J; Kowluru RA
J Cell Physiol; 2016 Aug; 231(8):1709-18. PubMed ID: 26599598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
